Forecasting The Future: 4 Analyst Projections For Gritstone Bio
During the last three months, 4 analysts shared their evaluations of Gritstone Bio (NASDAQ:GRTS), revealing diverse outlooks from bullish to bearish.In the table below, you'll find a summary of their
Express News | JMP Securities Reiterates Market Outperform on Gritstone Bio, Maintains $5 Price Target
JMP Securities Maintains Gritstone Bio(GRTS.US) With Buy Rating, Maintains Target Price $5
JMP Securities analyst Roy Buchanan maintains $Gritstone Bio(GRTS.US)$ with a buy rating, and maintains the target price at $5.According to TipRanks data, the analyst has a success rate of 32.2% and a
Express News | Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Gritstone Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PDF Version EMERYVILLE, Calif., June 13, 2024 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims to develop the world's most potent vaccine
Gritstone Bio to Participate in Upcoming Investor and Scientific Conferences
PDF Version EMERYVILLE, Calif., June 04, 2024 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the world's most potent vaccines,
12 Health Care Stocks Moving In Monday's After-Market Session
GainersFibroGen (NASDAQ:FGEN) stock moved upwards by 24.4% to $1.53 during Monday's after-market session. The market value of their outstanding shares is at $152.1 million. Candel Therapeutics (NASDAQ
B.Riley Financial Maintains Gritstone Bio(GRTS.US) With Buy Rating, Cuts Target Price to $3
B.Riley Financial analyst Mayank Mamtani maintains $Gritstone Bio(GRTS.US)$ with a buy rating, and adjusts the target price from $6 to $3.According to TipRanks data, the analyst has a success rate of
B. Riley Cuts Price Target on Gritstone Bio to $3 From $6, Keeps Buy Rating
Gritstone bio (GRTS) has an average investment rating of buy among analysts polled by Capital IQ, with price targets ranging from $3 to $7.
Gritstone Bio(GRTS.US) Officer Sells US$18,156 in Common Stock
$Gritstone Bio(GRTS.US)$ Officer Allen Andrew R sold 24,263 shares of common stock on May 16, 2024 at an average price of $0.7483 for a total value of $18,156.Source: Announcement What is statement of
Gritstone Bio(GRTS.US) Officer Sells US$6,928.51 in Common Stock
$Gritstone Bio(GRTS.US)$ Officer Hawryluk Matthew sold 9,259 shares of common stock on May 16, 2024 at an average price of $0.7483 for a total value of $6,928.51.Source: Announcement What is statement
Gritstone Bio(GRTS.US) Officer Sells US$10,288.38 in Common Stock
$Gritstone Bio(GRTS.US)$ Officer Economides Vassiliki sold 13,749 shares of common stock on May 16, 2024 at an average price of $0.7483 for a total value of $10,288.38. This transaction involves other
Beyond The Numbers: 4 Analysts Discuss Gritstone Bio Stock
In the latest quarter, 4 analysts provided ratings for Gritstone Bio (NASDAQ:GRTS), showcasing a mix of bullish and bearish perspectives.The following table provides a quick overview of their recent r
Gritstone Bio Is Maintained at Buy by HC Wainwright & Co.
Gritstone Bio Is Maintained at Buy by HC Wainwright & Co.
Gritstone Bio Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/13/2024 406.59% HC Wainwright & Co. $7 → $4 Maintains Buy 04/02/2024 533.23% JMP Securities $4 → $5 Mai
Express News | Gritstone bio, Inc. : H.c. Wainwright Cuts Target Price to $4 From $7
Express News | Gritstone bio Inc : Jonestrading Cuts Target Price to $5 From $10
Express News | Gritstone bio Shares Down 12.6% to $0.85 After Wider Q1 Loss
Why Natera Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket
Shares of Natera, Inc. (NASDAQ:NTRA) rose sharply in today's pre-market trading following strong first-quarter earnings.
12 Health Care Stocks Moving In Friday's Pre-Market Session
GainersAethlon Medical (NASDAQ:AEMD) stock moved upwards by 129.0% to $2.7 during Friday's pre-market session. The company's market cap stands at $7.1 million. Novavax (NASDAQ:NVAX) shares rose 119.23
No Data